Solvay's first Chinese plant for a key chemical disinfectant is now
fully operational, serving the growing Chinese market and spreading
the international chemical group's global reach ever further.
Pharmaceutical packaging and processing machinery specialist IMA
has announced its half year results, with its active expansion
plans paying dividends and its pharma business going strong.
The launch of Invitrogen's Stempro EZPassage should substantially
reduce the time and stress involved in dividing up cultures of
human embryonic stem cell (hESC) colonies.
UK Hikma Pharmaceuticals has acquired Egyptian pharmaceutical
company Alkan Pharma in a deal worth $60.5m (€44.2m), and
establishes the London-based company in the Egyptian market.
PerkinElmer has expanded its multi-vendor service offering to help
firms reduce the cost of regulatory compliance in pharmaceutical
drug development and manufacturing quality control laboratories.
A UK firm responsible for developing an innovative PEGylation
technology has landed a deal with a Canadian specialty chemicals
firm, allowing them to offer a complete package to companies
looking to work with the new technology.
GlaxoSmithKline (GSK) has suffered a blow in the advance of its top
selling pharma drug Advair after US regulators issued a not
approvable letter for an increased strength in the treatment of
chronic obstructive pulmonary disease.
Jeol has launched a new NMR (nuclear magnetic resonance)
spectrometer that brings a high performance instrument to routine
drug discovery and quality control applications, all in an 'entry
level' package.
French pharma firm Ipsen has gained marketing authorisation for
Increlex (mecasermin), the first therapy of its kind to be approved
in the EU for long term treatment of severe primary insulin-like
growth factor-1 deficiency (IGFD).
US-based Gilead Sciences has ditched its plans to build a new €60m
plant in Dublin, Ireland, instead acquiring Nycomed's Irish
manufacturing facility in Cork for almost €34m.
Baxter Healthcare remains in murky waters in regard to its infusion
pumps after announcing yesterday it would be recalling an
additional 986 of its Colleague brand pumps.
China has announced an initial $1.7bn investment to bolster its
currently questionable ability to effectively monitor the quality
of the food and drugs manufactured within its borders.
A US bankruptcy court judge ruled on Friday that Puerto Rican-based
pharma services firm Inyx USA be put under the control of an
independently-appointed trustee.
Celsis' Rapid Microbiological Method (RMM) has been included in GlaxoSmithKline's (GSK) successful Veramyst New Drug Application (NDA), paving the way for broader acceptance of the time saving technique.
German pharma firm Stada has acquired Russian pharmaceuticals group
Makiz in a deal worth up to €135m, giving the company a sturdy
foothold in the growing Russian market and enhanced in-house
production capacity.
LabTechnologist.com brings you an exclusive interview with Greg
Herrema - president of the Scientific Instruments division of
Thermo Fisher Scientific.
The latest twists and turns in the Inyx Inc. bankruptcy saga
include an attempted power seize by its creditor, fraud allegations
thrown around courtrooms and in the media, the resignation of Inyx'
accountants, and increasing...
Abraxis BioScience has snapped up another manufacturing plant in
its drive to expand production capabilities, this time announcing
the purchase of Watson Pharmaceuticals' sterile injectables plant.
Outsourcing Services Group (OSG) has announced it has sold its
contract manufacturing subsidiary OSG Norwich Pharmaceuticals to a
US private equity firm for an undisclosed amount.
Nikon have launched a new 'hands off' system that combines an
incubator and inverted microscope to allow automated live-cell
culture studies and time-lapse imaging in a controlled environment.
Indian biotech heavyweight Biocon has today announced that its
joint venture with Abu Dhabi-based Neopharma has spawned new
company NeoBiocon, operating out of one of Dubai's newest
biotechnology parks.
Rentschler Biotechnologie has completed the first phase of a €50m
expansion of its biomanufacturing capacity with the launch of two
new bioreactors aimed at making protein-based drugs for biopharma
clients.
Artel's extreme pipetting expedition team went to Yellowstone
National Park, US, where they found that pipetting hot or cold
liquids can cause delivery volume errors of up to 37 per cent.
A novel spring-powered inhaler system to deliver the blockbuster
COPD (chronic obstructive pulmonary disease) treatment Spiriva
(tiotropium) has successfully completed the EU approval process,
paving the way for its introduction into...
French firm Vivalis has announced the first data evaluating its
proprietary EBx cell lines for the production of monoclonal
antibodies (MAbs), with initial results suggesting high cytotoxic
properties in the resultant MAbs.
Lab equipment specialist Sotax has announced the creation of a new contract research organisation (CRO) focused exclusively on dissolution testing services.
Ever since Bio-Rad's acquisition of Ciphergen's SELDI MS (surface
enhanced laser desorption/ionisation mass spectrometry) technology
late last year, it has been fighting against the spectre of
"controversial" research...
Biocatalysis expert Codexis has acquired BioCatalytics for an
undisclosed amount to strengthen its off-the-shelf biocatalyst
portfolio and give itself a larger 'window to the market'.
German speciality chemicals firm CABB has scooped up Swiss company
SF-Chem in a deal set to create a leading European supplier of
chlorine and speciality intermediates.
Danish firm Novozymes has been honoured by animal rights
organisation PETA for its efforts to provide animal-free
bioprocessing methods aimed at cutting animal testing during drug
development.
The US Food and Drug Administration (FDA) has released a draft
guideline document outlining a model for implementing the
International Conference on Harmonization's (ICH) Q10.
Microscopy expert, Carl Zeiss has shipped the world's first
commercial helium ion microscope that promises to allow researchers
to view objects at higher resolutions than ever before.
Swiss researchers have developed a method that combines bacterial
capture, lysis and the purification of plasmid DNA to improve
industrial-scale bioprocesses.
US biopharmaceutical company VGX has strengthened its position in
the plasmid DNA area with the award of two new patents covering the
use and manufacture of plasmid DNA.
UK-based deltaDOT has been given a key role providing analytical
technologies to a consortium aiming to increase the efficiency of
vaccine and biological drug production.
A drug developed from the milk of transgenic animals is one step
closer to being the second such drug on the market following a
European thumbs up of its facilities, marking a significant move in
the controversial drug development...
University of Texas at Arlington (UTA) spin-out has exclusively
licensed plasma coating technology that could improve the
controlled release of drugs and the biocompatibility of medical
implants.
LabTechnologist.com brings you an exclusive interview with Ger
Brophy - general manager of Advanced Systems within GE Healthcare's
Life Science Division.
As Outsourcing-Pharma.com continues to investigate the
circumstances of the Inyx group's insolvency problems, it can
be revealed that some of the senior management have been
involved at a senior level in other firms that have...
LabTechnologist.com brings you its periodic round up of new product
releases, with new offerings from Activotec, Luminex, Nonlinear
Dynamics, Oxford Gene Technology, SP Industries, TandD, Thermo
Fisher Scientific and VWR.
Sigma-Aldrich is to collaborate with Sangamo BioSciences to develop
zinc finger DNA-binding proteins to create knock-out cell lines and
cell lines with enhanced protein production performance.
Almost the entire international operations of specialty pharma
contract manufacturer Inyx is facing insolvency and the company is
locked in a legal battle with its principal financier.
Indian pharmaceutical manufacturing company Shasun Chemicals and
Drugs has now got its eye fully on the US market after recent
approval of its new formulation facility in Puducherry.
Indian contract manufacturing organisation (CMO) Dishman
Pharmaceuticals has announced its plans to buy Solvay
Pharmaceuticals' fine chemicals and vitamin businesses for an
undisclosed sum.
